Vince Michael Vismara, M.D.

Vince Michael Vismara, M.D.




  • Internal Medicine
  • Cardiovascular Medicine
  • Interventional Cardiology


  • USMLE Step I, Step II and STEP III – passed
  • Internal Medicine – board certified, August 2000
  • Cardiovascular Disease – board certified, November 2003
  • Recertified in November 2013
  • Interventional Cardiology – board certified, November 2004
  • Recertified in November 2014
  • South Carolina State Physician Licensure #29716
  • Drug Enforcement Administration Registration #BV7095501
  • South Carolina Controlled Substances Practitioner #20-29716


  • St. Louis University 1988 – 1992, Bachelors of Arts: Psychology – Graduated Cum Laude
  • St. Louis University 1992 -1993, Post Baccalaureate Studies in Anatomy
  • St. Louis University School of Medicine 1993 – 1997, Doctorate of Medicine

Post Graduate Education

  • University of Connecticut Health Center 1997 – 2000, Internal Medicine Residency
  • UMASS/St. Vincent Hospital 2000 – 2003, Cardiovascular Medicine Fellowship
  • UMASS/St. Vincent Hospital 2003 – 2004, Interventional Cardiovascular Medicine Fellowship

Professional Affiliations

  • Fellow of Society for Cardiovascular Angiography and Interventions
  • Fellow of the American College of Cardiology
  • Assistant Professor of Clinical Internal Medicine – University of SC School of Medicine


  1. Measurement of Brain Natriuretic Peptide Levels During Stress Myocardial Perfusion Imaging in Attempt to Quantify its Response to Ischemia
  2. ARRIVE 2- US Safety Registry for the TAXUS Express 2 Paclitaxal-Eluting Stent Co-Investigator
  3. CHAMPION PCI Study- Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition- Principal Investigator
  4. SPIRIT IV Clinical Trial- A Clinical Evaluation of the XIENCE V Everolimus Eluting Coranary Stent System in the Treatment of Subjects with De Novo Native Coronary Artery Lesions- Co Investigator
  5. DART Study- Diagnosing Adverse Drug Reactions Registry-Regional Principal Investigator
  6. PLATINUM Diversity Study- Outcomes with Promus PREMIER Stent in Women and Minorities- Principal Investigator
  7. LOWER Study-Lomitapide Observational Worldwide Evaluation Registry-Principal Investigator
  8. TWILIGHT Study-Ticagrelor with Asprin or Alone in High Risk Patients after Coronary Intervention-Co Investigator
  9. EMPEROR-Preserved Study-Empagliflozin Out Come Trial in Patients with Chronic Heart Failure with Preserved Injections Fraction- Co Investigator
  10. PROVIDE Study-Patient Reported Outcomes In Vestigation following Initiation of Drug Therapy with Entresto (Sacubitril/Valsarten) in Heart Failure-Co Investigator

Leadership Positions

  • Prisma Health Cardiovascular Council-Cardiovascular Representative
  • Director of the Catheterization Lab,Richland Medical Center,Palmetto Health October 2013-Present
  • Director of the Peripheral-Cardiovascular Clinic, Fallon Clinic 2005-2007
  • Vision 20/20-Boston Scientific- Advisor/Contributor Targeted at Building Collaboration with Physician Leaders on Emergent Product Technologies Service Initiatives and Unmet Clinical Needs.




Outstanding Medical Educator as Acknowledged by the Department of Medicine of St. Vincent Hospital at Worcester Medical Center, June 2001, 2002 and 2003.

Interest and Activities

Golf, Running, Hunting, Fishing